Updated formulas from Pfizer, Moderna, and Novavax target the circulating XFG variant for older adults and high-risk ...

Inhalation Solution would become the first inhaled option designed to treat idiopathic pulmonary fibrosis (IPF).

FDA will review Enflonsia's ability to protect high-risk children under 2 years of age during their second RSV season.

A clinical trial will evaluate a weekly dry powder nasal spray's ability to boost natural defenses and prevent asthma infections.

The American Lung Association provides personalized guidance from RTs and nurses to help pulmonary fibrosis patients manage ...

CVS and Walgreens are expanding walk-in access, multi-vaccine scheduling, and respiratory illness testing ahead of peak viral activity.

The ERS is urging European countries to adopt "tobacco endgame" policies to permanently reduce tobacco use and end the ...

The discovery of sorting nexin 5 provides insight into how the body signals infection and manages tissue damage.

The latest round of products brings the total number of FDA-authorized flavored nicotine pouches to 43 overall.

UCLA Health combines biopsy, staging, and surgery into a single session to reduce delays and improve lung cancer patient ...

California is launching a statewide initiative to provide free asthma inhalers and spacers to 10,000 public and charter ...

A study of more than 14,000 lung cancer patients suggests age influences tumor biology and the availability of targeted ...